Our Customers

Customer page hero image

ENABLING A TOP 3 PHARMA LEADER TO BOOST EFFECTIVE­NESS FOR REPS

Even during a pandemic

Life Sciences field teams have experienced a massive transition due to restricted access to healthcare professionals (HCPs). The new normal means limited in-person appointments and the need for more digital and omnichannel engagement. Read the transformational story about a global pharma leader providing a true sense of purpose to its field force, while also finding ways to collect feedback and turn them into insights for all stakeholders.

TRUSTED BY LIFE SCIENCES & TECHNOLOGY LEADERS

HOW NOVARTIS IS USING AI TO IMPROVE CUSTOMER ENGAGEMENt

GLOBAL
TRANS­FORMATION

Powered by
tact.ai logo
tact on map

Users in 50+ countries

Supporting 9 languages

OUR CUSTOMERS LOVE US

Tact.ai accelerates revenue growth and improves the Sales and Customer Experience for sales teams

DRIVE CRM COMPLIANCE

222%

More events and contacts were created post Tact implementation

IMPACT PERFORMANCE

170%

More pipeline, deals won and revenue over non-Tact users

REDUCE ADMIN TIME

72%

Users preferred the ease of Tactover current CRM

5 start icon

EASILY TACKLE YOUR FIELD SALES ROLE FROM THE ROAD!

"Tact makes it easy to access customer data and submit Trip Reports on the fly, so you can maximize your day and reduce time spent on administrative tasks."

TINA P
Dell EMC
Tact.ai G2 Medal

TESTIMONIALS

It’s refreshing to work with a company that understands the significance of each interaction – whether on camera, over chat, or face-to-face – has on improving patient outcomes. I’m very pleased to join Tact.ai’s mission of helping deliver innovative medicines to patients faster.”​

Desmond Creary

Desmond Creary

Chief Customer Engagement Officer, Novartis US

“Tact’s platform helps teams have better interactions with customers by getting them prepared, supporting all and new emerging channels of interaction, and closing the loop so insights are captured. I believe Tact has an opportunity to definitely create a more innovative and positive impact on how pharma and HCPs collaborate.”​

Giuseppe Firenze

Giuseppe Firenze

VP and Global CIO, Business Units at Eli Lilly

"The flexibility Tact offers has allowed us to tailor our processes to fit our specific needs, resulting in a competitive advantage. Since integrating the tact.ai, our team's efficiency has greatly improved. Its user-friendly interface made onboarding a breeze, and its smooth compatibility with our existing systems eased the integration process. A standout feature is its reliability – it works flawlessly "

Robert Dziambor

Robert Dziambor

Customer & Commercial Excellence Lead, Bayer Germany & Austria

"By offering a secure and seamless user experience that enables field teams to personalize each interaction with their customers and capture more insights, Tact is helping commercial and medical teams orchestrate the type of high-quality engagement that customers demand today."

Lana Ghanem

Lana Ghanem

Managing Director of Hikma Ventures. ​

“These are the tools they will actually use in the new kind of ecosystem that we are working upon. This is where our partnership with Tact has come into play, because this is exactly what we want to focus on: the user experience, data capture, being always on and moving from 9-to-5, to a 24-hour cycle of being able to access data, when needed.”

Stan Tsvirko

Stan Tsvirko

Executive Director, Head Digital Medical Affairs Novartis

“Being focused on the experience, giving customers more choice and flexibility, paired with the nimbleness needed to adapt to changing market requirements is in the DNA of Tact.ai and its leading engagement platform"

Andreas Müller

Andreas Müller

Advisor and Chair of Tact.ai's Customer Advisory Board

“Our Commercial and Medical teams at Novartis have been collaborating with Tact over the last two years to transform our field force and customer experience globally. Tact.ai aligns with our ambition to reimagine customer engagement for the New Normal”

Rana Lonnen

Rana Lonnen

Managing Director at dRx Capital

NEED MORE CONVINCING?